|
|
Volumn 33, Issue 7-8, 2001, Pages 3211-3212
|
|
Study of Simulect-based, steroid-free immunosuppressive regimen in HCV+ de novo liver transplant patients: Preliminary results
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
PLACEBO;
PREDNISOLONE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
LIVER BIOPSY;
LIVER DYSFUNCTION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PATIENT SELECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURGICAL PATIENT;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RECOMBINANT FUSION PROTEINS;
RECURRENCE;
STEROIDS;
TREATMENT FAILURE;
|
|
EID: 0035678813
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02367-3 Document Type: Article |
|
Times cited : (12)
|
|
References (6)
|
